CTOs on the Move

Sunset Manor

www.sunsetmanor.com

 
Sunset Manor is a Geneva, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Erba Diagnostics

ERBA Diagnostics Inc., is a part of the global ERBA Mannheim Group. Earlier known by the name of IVAX Diagnostics, the company specializes in manufacture and marketing of proprietary diagnostic reagents, test kits and instrumentation in the areas of autoimmune, chemistry, hematology, diabetes and infectious diseases. ERBA Diagnostics has further strengthened ERBA Group`s comprehensive portfolio of instrument and reagent solutions, covering all levels of automation and throughput needs of laboratories across the world. With its team of experienced marketing, technical and service professionals and a strong and extensive distribution network the company lives up to the ERBA Group`s philosophy of consistently delivering excellence through innovation, technology and customer service.

Welch Allyn Inc.

Welch Allyn Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Skaneateles Falls, NY. To find more information about Welch Allyn Inc., please visit www.welchallyn.com

HealthTrio LLC

HealthTrio LLC is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

P.volve

P.volve is a rapidly growing start-up and omnichannel health & wellness brand with an on-demand movement platform, a patented equipment line, three studio locations, franchise opportunities worldwide and a recovery supplement. Our team is comprised of highly passionate, hardworking professionals who live and breathe our Method and business. When a team member starts at P.volve, they will feel the infectious positivity and dedication to our mission.

Wave Life Sciences

WAVE Life Sciences is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering exceptional treatment options for patients. Given the unique versatility of its chemistry platform, WAVE`s pipeline will span multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded RNAi.